Related Experiment Video
Updated: Oct 25, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Bloodstream infections in patients with transcatheter aortic valve replacement
Khawaja M Talha1, Jack W McHugh2, Daniel C DeSimone3
1Division of Infectious Diseases, Department of Medicine, Mayo Clinic School of Medicine and Science, Rochester, MN, USA.
Objective:
To evaluate incidence and risk factors of bloodstream infections (BSI) in patients with transcatheter aortic valve replacement (TAVR).
Methods:
We conducted a population-based study in southeastern Minnesota using the expanded Rochester Epidemiology Project (e-REP) for all adult (≥18 years) patients who underwent TAVR from January 1, 2010 to December 31, 2018.
Results:
The incidence of BSI following TAVR was 1300 episodes/100,000 persons per annum. The median time to BSI following TAVR was 610 days and 84% were community-acquired. Forty percent of BSI cases developed infective endocarditis. Viridans group streptococci (VGS) were the most common pathogens and 80% of patients with VGS BSI had IE.
Conclusions:
The high incidence of BSI among TAVR patients is alarming and is likely due to advanced age and comorbid conditions. Because 40% of BSI patients also developed IE, further investigation of modifiable risk factors associated with BSI is warranted.
Insights
Bloodstream infections (BSI) are alarmingly common after transcatheter aortic valve replacement (TAVR). Many BSIs lead to infective endocarditis, highlighting the need to study risk factors in TAVR patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Transcatheter aortic valve replacement (TAVR) is a growing procedure for aortic stenosis.
- Understanding post-procedural complications like bloodstream infections (BSI) is crucial.
Purpose of the Study:
- To determine the incidence and identify risk factors for bloodstream infections (BSI) in patients who have undergone transcatheter aortic valve replacement (TAVR).
Main Methods:
- A population-based study was conducted in southeastern Minnesota.
- Data were collected from adult patients (≥18 years) who underwent TAVR between January 1, 2010, and December 31, 2018, using the expanded Rochester Epidemiology Project (e-REP).
Main Results:
- The incidence of BSI post-TAVR was 1300 episodes per 100,000 person-years.
- The median time to BSI was 610 days, with 84% being community-acquired.
- Forty percent of BSI cases progressed to infective endocarditis (IE), with Viridans group streptococci (VGS) being the most common pathogen (80% of VGS BSI cases had IE).
Conclusions:
- The high incidence of BSI in TAVR patients is concerning, likely linked to advanced age and comorbidities.
- The significant rate of IE developing from BSI warrants further investigation into modifiable risk factors.
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Endocarditis I: Introduction
Endocarditis III: Medical Management
Aortic Regurgitation III: Medical Management